Reactive granulomatous dermatitis: A retrospective cohort study of 65 patients - 19/05/25
Doi : 10.1016/j.jaad.2025.02.012
Tejashri Venkatesh, BS a, Flavia Fedeles, MD b, c, ⁎ 
a Chicago Medical School at Rosalind Franklin University, North Chicago, Illinois
b Harvard Medical School, Boston, Massachusetts
c Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts
∗ Correspondence to: Flavia Fedeles, MD, Department of Dermatology, Massachusetts General Hospital, 50 Staniford Street, Suite 200, Boston, MA 02114 Department of Dermatology Massachusetts General Hospital 50 Staniford Street Suite 200 Boston MA 02114
Key words : Reactive granulomatous dermatitis, interstitial granulomatous dermatitis, granuloma annulare, autoimmune, comorbidity, malignancy, hydroxychloroquine
| Funding sources: None. |
|
| Patient consent: Not applicable. |
|
| IRB approval status: Approved by the Mass General Brigham IRB (Protocol No. 2022P003033). |
|
| An abstract containing the findings discussed in this study was accepted for poster presentation at the American Society of Dermatopathology 2024 Annual Meeting, Chicago, IL, November 7-10, 2024. |
© 2025
American Academy of Dermatology, Inc.. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Vol 92 - N° 6
P. 1410-1412 - juin 2025 Regresar al número
Artículo precedente
- Topical corticosteroid exposure is not associated with increased risk of pregnancy complications in a large population-based cohort study of psoriasis patients
- Amit Singal, Shari R. Lipner
- Improved patient satisfaction and overall experience in the postoperative period utilizing visual education on wound healing for primary closures: A prospective cohort study
- Shirley Lin, Aaron Bao, Daniela Barata Herrera, Emanuelle Rizk, Chi Trinh, Luke Zhao, Calvin O'Donnell, Rachel De Armas, Erina Lie, Ashley Antony, Karina Paci, Elise Ng, Jeffrey Scott, Kristin Bibee
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?